CardioFocus today said it appointed Stephan Ogilvie as chief financial officer.
Prior to joining the Marlborough, Mass.-based company, Ogilvie served as managing director of healthcare investment banking at B Riley Securities. He has also served as VP of corporate development at Nuvasive and has held numerous leadership roles at ThinkEquity Partners, Lazard Capital Markets and Medtronic.
“Steve possesses deep experience in the healthcare industry, including a diverse background across key operational roles at medical device companies, as well as within the medical device sector on Wall Street,” CEO Burke Barrett said in a news release. “His expertise will be highly valuable as we work to drive the adoption of HeartLight X3 in the U.S. and internationally during this period of significant growth.”
“CardioFocus is bringing important innovation to the Afib ablation space with its recently launched HeartLight X3,” Ogilvie said. “There is a massive opportunity to bring the advanced capabilities of X3 to major markets across the globe, and I look forward to working with the organization to meet global demand for X3 during this high-growth commercial phase.”
